Ul­tragenyx nix­es plan to seek quick OK for rare dis­ease drug in Eu­rope

Faced with a push­back from Eu­ro­pean reg­u­la­tors, Ul­tragenyx to­day says that it is jerk­ing its ap­pli­ca­tion for a con­di­tion­al ap­proval of its drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.